Activation of the Aryl hydrocarbon receptor during pregnancy in the mouse alters mammary development through direct effects on stromal and epithelial tissues

Biology of Reproduction

Volumn 84, Issue 6, 2011, Pages 1094-1102

  Lew, Betina J ^c   Manickam, Ravikumar ^a   Lawrence, B Paige ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Agalactia; Alveolarization; Environment; Environmental factors; Lactation; Lactogenesis; Mammary glands; TCDD; Toxicology

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DNA BINDING; EPITHELIUM CELL; EX VIVO STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; MALE; MILK PRODUCTION; MOUSE; MUTANT; NONHUMAN; PARACRINE SIGNALING; PREGNANCY; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; SIGNAL TRANSDUCTION; STROMA;

ANIMALS; DNA; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; FEMALE; GENE EXPRESSION REGULATION; MAMMARY GLANDS, ANIMAL; MICE; PREGNANCY; PROTEIN BINDING; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN;

MUS;

EID: 79958243359     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.110.087544     Document Type: Article

References (63)

1. Robinson G, McKnight R, Smith G, Henninghausen L. Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 1995; 121:2079-2090
2. Hovey R, Trott J, Vonderhaar B. Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mam Gland Biol Neoplasia 2002; 7:17-38
3. Neville M, McFadden T, Forsyth I. Hormonal regulation of mammary gland differentiation and milk secretion. J Mam Gland Biol Neoplasia 2002; 7:49-66
4. Henninghausen L, Robinson G. Information networks in the mammary gland. Nat Rev Mol Cell Biol 2005; 6:715-725
5. Hovey R, McFadden T, Akers R. Regulation of mammary gland growth and morphogenesis by the mammary fat pad: a species comparison. J Mam Gland Biol Neoplasia 1999; 4:53-68
6. Neville M, Medina D, Monks J, Hovey R. The mammary fat pad. J Mam Gland Biol Neoplasia 1998; 3:109-116
7. Enoch R, Stanko J, Greiner S, Youngblood G, Rayner J, Fenton SE. Mammary gland development as a sensitive end point after acute prenatal exposure to an atrazine metabolite mixture in female Long-Evans rats. Environ Health Persp 2007; 115:541-547
8. Jedrychowsi W, Perara F, Mroz E, Edwards S, Flak E, Rauh V, Pac A, Budzyn-Mrozek D, Musial A. Prenatal exposure to passive smoking and duration of breastfeeding in nonsmoking women: Krakow inner city prospective cohort study. Arch Gynecol Obstet 2008; 278:411-417
9. Lew B, Collins LL, O'Reilly MA, Lawrence BP. Activation of the aryl hydrocarbon receptor during different critical windows in pregnancy alters mammary epithelial cell proliferation and differentiation. Toxicol Sci 2009; 111:151-162
10. Neville M, Walsh C. Effects of xenobiotics on milk secretion and composition. Amer J Clin Nutr 1995; 61:687S-694S
11. Soto AM, Vandenberg LN, Maffini M, Sonnenschein C. Does breast cancer start in the womb? Basic Clin Pharmacol Toxicol 2008; 102:125- 133
12. Vorderstrasse BA, Fenton SE, Bohn A, Cundiff J, Lawrence BP. A novel effect of dioxin: exposure during pregnancy severely impairs mammary gland differentiation. Toxicol Sci 2004; 78:248-257
13. Nguyen LP, Bradfield CA. The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 2008; 21:102-116
14. Denison M, Nagy S. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Phramacol Toxicol 2003; 43:309-334
15. Gasiewicz TA, Henry EC, Collins LL. Expression and activity of aryl hydrocarbon receptors in development and cancer. Crit Rev Eukaryot Gene Expr 2008; 18:279-321
16. Gu Y-Z, Hogenesch J, Bradfield C. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Phramacol Toxicol 2000; 40:519-561
17. Puga A, Ma C, Marlowe JL. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 2009; 77:713-722
18. Lahvis G, Bradfield CA. AHR null alleles: distinctive or different? Biochem Pharmacol 1998; 56:781-787
19. Gonzalez F, Fernandez-Salguero PM. The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab Dispos 1998; 26:1194-1198
20. Benedict J, Lin T-M, Loeffler I, Peterson R, Flaws J. Physiological role for the aryl hydrocarbon receptor in mouse ovary biology. Toxicol Sci 2000; 56:382-388
21. Lund AK, Peterson SL, Timmins GS, Walker MK. Endothelin-1-mediated increase in reactive oxygen species and NADPH oxidase activity in hearts of aryl hydrocarbon receptor (AHR) null mice. Toxicol Sci 2005; 88:265-273
22. Cunha G, Cook P, Kurita T. Role of stromal-epithelial interactions in hormonal responses. Arch Histol Cytol 2004; 67:417-434
23. Hushka L, Williams J, Greenlee W. Characterization of 2,3,7,8-tetrachlorodibenzofuran-dependent suppression and Ah receptor pathway gene expression in the developing mouse mammary gland. Toxicol Appl Pharmacol 1998; 152:200-210
24. Le Provost F, Riedlinger G, Yim S, Benedict J, Gonzalez F, Flaws J, Henninghausen L. The aryl hydrocarbon receptor (AHR) and its nuclear translocator (ARNT) are dispensible for normal mammary gland development but are required for fertility. Genesis 2002; 32:231-239
25. Henninghausen L, Robinson G. Think globally, act locally: the making of a mouse mammary gland. Genes Dev 1998; 12:449-455
26. Henninghausen L, Robinson G. Signaling pathways in mammary gland development. Develop Cell 2001; 1:467-475
27. Hovey R, Trott J. Morphogenesis of mammary gland development. Adv Exp Med Biol 2005; 554:219-228
28. Fernandez-Salguero P, Pineau T, Hilbert D, McPhail T, Lee S, Kimura S, Nebert D, Rudikoff S, Ward J, Gonzalez F. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995; 268:722-726
29. Bunger M, Glover E, Moran SM, Walisser J, Lahvis G, Hsu EL, Bradfield CA. Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA binding domain of the aryl hydrocarbon receptor. Toxicol Sci 2008; 106:83-92
30. Poland A, Palen D, Glover E. Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol Pharmacol 1994; 46:915-921
31. Takemoto K, Nakajima M, Jujiki Y, Katoh M, Gonzalez F, Yokoi T. Role of the aryl hydrocarbon receptor and CYP1B1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Toxicol 2004; 78:309-315
32. Gasiewicz T, Geiger L, Rucci G, Neal R. Distribution, excretion and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J, DBA/2J and B6D2F1 mice. Drug Metab Dispos 1983; 11:397-403
33. Chapman D, Schiller C. Dose-related effects of 2,3,7,8-tetrachlorodiben-zo-p-dioxin in C57BL/6J and DBA/2J mice. Toxicol Appl Pharmacol 1985; 78:147-157
34. Young L. The cleared mammary fat pad and the transplantation of mammary gland morpholoical structures and cells.In: Ip MM, Asch B(eds.), Methods in Mammary Gland Biology and Breast Cancer Research. New York: Kluwer Academic/Plenum Publishers; 2000:67-74
35. Plaut K, Ikeda M, Vanderhaar B. Role of growth hormone and insulin-like growth factor-1 in mammary development. Endocrinology 1993; 133:1843-1848
36. Singh D, DeOme K, Bern H. Strain differences in response of the mouse mammary gland to hormones in vitro. J Natl Cancer Inst 1970; 45:657- 675
37. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li H, Eaves C. Purification and unique properties of mammary epithelial stem cells. Nature 2006; 439:993-997
38. Schefe J, Lehmann K, Buschmann I, Unger T, Funk-Kaiser H. Quantitative real time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. J Mol Med 2006; 84:901-910
39. Collins LL, Lew BJ, Lawrence BP. TCDD exposure disrupts mammary epithelial cell differentiation and function. Repro Toxicol 2009; 28:11-17
40. Diry M, Tomkiewicz C, Koehle C, Coumoul X, Walter Bock K, Barouki R, Transy C. Activation of the dioxin/aryl hydrocarbon receptor (AHR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene 2006; 25:5570-5574
41. Qu X, Metz R, Porter W, Cassone V, Earnest D. Disruption of clock gene expression alters responses of the aryl hydrocarbon receptor signaling pathway in the mouse mammary gland. Mol Pharmacol 2007; 72:1349- 1358
42. John K, Divi R, Keshava C, Orozco C, Schockley M, Richardson D, Poirier M, Nath J, Weston A. CYP1A1 and CYP1B1 gene expression and DNA adduct formation in normal human mammary epithelial cells exposed to benzo[a]pyrene in the absence or presence of chlorophyllin. Cancer Lett 2010; 292:254-260
43. Qu X, Metz R, Porter W, Neuendorff N, Earnest B, Earnest D. The clock genes period 1 and period 2 mediate diurnal rhythms in dioxin-induced Cyp1A1 expression in the mouse mammary gland and liver. Toxicol Lett 2010; 196:28-32
44. Abbott B, Held G, Wood C, Buckalew A, Brown J, Schmid J. AHR, ARNT, and CYP1A1 mRNA quantitation in cultured human embryonic palates exposed to TCDD and comparison with mouse palate in vivo and in culture. Toxicol Sci 1999; 47:62-75
45. Mitchell K, Lockhart C, Huang G, Elferink C. Sustained aryl hydrocarbon receptor activity attenuates liver regeneration. Mol Pharmacol 2006; 70:163-170
46. Latchney S, Lioy D, Henry EC, Gasiewicz TA, Strathmann F, Mayer-Proschel M, Opanashuk LA. Neural precursor cell proliferation is disrupted through activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Stem Cells Dev 2011; 20:313-326
47. Miller K, Borgeest C, Greenfeld C, Tomic D, Flaws J. In utero effects of chemicals on reproductive tissues in females. Toxicol Appl Pharmacol 2004; 198:111-131
48. Vezina C, Lin T, Peterson R. AHR signaling in prostate growth, morphogenesis, and disease. Biochem Pharmacol 2009; 77:566-576
49. Grimm S, Seagroves T, Kabotyanski E, Hovey R, Vonderhaar B, Lydon J, Miyoshi K, Hennighausen L, Ormandy C, Lee A, Stull M, Wood T, et al. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol Endocrinol 2002; 16:2675-2691
50. Luetteke N, Qiu T, Fenton S, Troyer K, Riedel R, Chang A, Lee D. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 1999; 126:2739-2750
51. Moraes R, Change H, Harrington N, Landua J, Prigge J, Lane T, Wainwright B, Hamel P, Lewis M. Ptch1 is required locally for mammary gland morphogenesis and systemically for ductal elongation. Development 2009; 136:1423-1432
52. Puga A, Xia Y, Elferink C. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact 2002; 141:117-130
53. Barnes-Ellerbe S, Knudsen K, Puga A. 2,3,7,8-Tetrachlorodibenzo-pdioixin blocks androgen-dependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation. Mol Pharmacol 2004; 66:502-511
54. Barhoover M, Hall J, Greenlee W, Thomas R. Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4. Mol Pharmacol 2009; 77:195-201
55. Mathew LK, Simonich MT, Tanguay RL. AHR-dependent misregulation of Wnt signaling disrupts tissue regeneration. Biochem Pharmacol 2009; 77:498-507
56. Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 1995; 9:2364-2372
57. Sicinski P, Donaher J, Parker S, Li T, Fazeli A, Gardner H, Haslam S, Bronson R, Elledge S, Weinberg R. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995; 82:621- 630
58. Knudsen K, Wheelock M. Cadherins and mammary gland. J Cell Biochem 2005; 95:488-496
59. Barcellos-Hoff M, Aggeleer J, Ram T, Bissell M. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membranes. Development 1989; 105:223-235
60. Lanigan F, O'Connor D, Martin FM, Gallagher W. Molecular links bewtween mammary gland development and breast cancer. Cell Mol Life Sci 2007; 64:3159-3184
61. Jenkins S, Rowell C, Wang J, Lamartiniere C. Prenatal TCDD exposure predisposes for mammary cancer in rats. Repro Toxicol 2007; 23:391- 396
62. Schlezinger J, Liu D, Farago M, Seldin D, Belguise K, Sonenshein G, Sherr D. A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biol Chem 2006; 387:1175-1187
63. Warner M, Eskenazi B, Mocarelli P, Gerthoux P, Samuels S, Needham L, Patterson D, Brambilla P. Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environ Health Perspect 2002; 110:625-628.